John H. Johnson

John H. Johnson currently serves as Executive Chairman of Applied Therapeutics, Inc. since December 2024 and has held various board member positions at companies including axogen, Xeris Pharmaceuticals, and Verastem Oncology since 2021, accompanied by a directorship at Reaction Biology until March 2025. Previously, John was Chairman of Autolus Ltd. until June 2023 and held a board member role at BioAgilytix until December 2021. As Chief Executive Officer and Executive Chairman of Strongbridge Biopharma plc from March 2015 to October 2021, John also contributed to Portola Pharmaceuticals as a board member until July 2020 and led Melinta Therapeutics as Chief Executive Officer from July 2009 to September 2019. Academic credentials include a Bachelor of Science degree from East Stroudsburg University of Pennsylvania and further studies at the University of Rochester - Simon Business School and the University of Pittsburgh.